<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00288860</url>
  </required_header>
  <id_info>
    <org_study_id>TEL 03-135</org_study_id>
    <nct_id>NCT00288860</nct_id>
  </id_info>
  <brief_title>Telephone Case Monitoring (TCM) for Veterans With Post-Traumatic Stress Disorder (PTSD)</brief_title>
  <acronym>TCM-PTSD</acronym>
  <official_title>Telephone Case Monitoring for Veterans With PTSD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test whether providing PTSD patients additional support by
      telephone (in addition to usual outpatient care) after they discharge from residential
      treatment improves those patients' outcomes and keeps them out of the hospital longer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Poor compliance with aftercare may contribute to high rates of relapse and
      rehospitalization among Veterans who received residential treatment for posttraumatic stress
      disorder (PTSD). Telephone case monitoring has been shown to improve treatment adherence and
      reduced relapse among patients with chronic medical and substance use disorders, but has not
      been tested in PTSD patients.

      Objectives: This multisite randomized controlled trial tested whether augmenting usual
      aftercare with telephone monitoring improved resulted in 1) improved clinical outcomes (less
      violence, substance use, and PTSD symptoms; 2) longer time to rehospitalization; 3) better
      compliance with aftercare in the year after discharge from residential treatment for PTSD.

      Methods: This trial recruited 837 subjects from 6 PTSD residential treatment programs at 5 VA
      medical centers, 94.7% of the 884 projected. Patients who completed at least 14 days of
      residential PTSD treatment and discharged to VA outpatient care were eligible to participate.
      Subjects were randomized to usual aftercare care (n = 425) or usual aftercare plus biweekly
      telephone case monitoring calls during the first three months after discharge (n = 412).
      Telephone case monitors assessed current problems, encouraged treatment adherence, provided
      problem-solving support, and alerted providers to emergent care needs. Patient self-report
      measures of psychiatric symptoms, substance use, and violence were obtained at intake to
      residential treatment and 4 months (69% completion rate) and 12 months (64% completion rate)
      after discharge. Retention was lower than the investigators' planned 70% to 75% rate due to
      difficulty locating some patients who moved (even their collateral informants did not know
      where they were) and 45 participants asking to discontinue due to lack of time (n = 10),
      general dissatisfaction with VA (n = 6), distress during phone calls (n = 5), dissatisfaction
      with compensation (n = 1), or no specified reason (n = 24). Treatment utilization data was
      obtained from the VA National Patient Care Database.

      Intent-to-treat analyses used mixed modeling to compare clinical outcomes in the telephone
      monitoring and usual care groups and 4 and 12 months after discharge. Survival analysis was
      used to compare conditions on time to rehospitalization. Having a slightly
      smaller-than-intended sample size resulted in modest reductions in statistical power, e.g.,
      power to detect the expected d = .25 effect on PTSD outcomes was reduced from about 90% to
      82%, and power to detect the anticipated W = .105 difference in rehospitalization rates was
      reduced from 88% to 85%. Secondary analyses assessed whether differences in outcomes between
      the telephone case monitoring and usual care groups were mediated by attending more
      outpatient visits and completing more medication refills. Exploratory analyses examined
      whether the effect of telephone support on the clinical outcome measures, number of treatment
      visits, and medication refills was moderated by number of outpatient mental health visits in
      the prior year, distance from clinic, treatment expectancies, therapeutic alliance, or
      co-occurring substance use problems.

      Status: Enrollment, intervention, data collection, and primary analyses are completed.
      Primary results have been published in Psychiatric Services (Rosen, Tiet, Harris et al.,
      2013) and two secondary papers have been published in the Journal of Traumatic Stress
      (Belsher, Tiet, Garvert, &amp; Rosen, 2012; Rosen, Adler, &amp; Tiet, 2013).

      A CDMRP-funded study extending this approach to PTSD outpatients at the Durham, Puget Sound
      and Palo Alto VA medical centers has recently been completed. Initial results of that second
      trial suggest that telephone care management improved treatment attendance but had weak
      effects on outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Aggressive Behavior; Alcohol Misuse; Drug Misuse; PTSD Symptoms</measure>
    <time_frame>12 months post-discharge (8 months post intervention)</time_frame>
    <description>Higher scores are worse outcomes on all four measures:
Aggressive behavior (scale from 0-6 types of violent behavior than past four months) - adapted from conflict tactics scale Alcohol problems: Addiction Severity Index Alcohol composite (ranges from 0 to 1) Drug problems: Addiction Severity Index Drug composite (ranges from 0 to 1) PTSD symptoms: DSM IV PTSD Checklist (ranges from 17 to 85)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rehospitalization</measure>
    <time_frame>12 months post discharge</time_frame>
    <description>Number of patients with psychiatric hospitalization within 12 months of discharge from PTSD program</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Depressive Symptoms, Subjective Quality of Life</measure>
    <time_frame>12 months post-discharge (8 months post intervention)</time_frame>
    <description>Depression: Center for Epidemiological Studies Scale (ranges from 0 to 60, with higher scores indicating worse depression) Quality of Life: Scale from the Veterans Affairs Military Stress Treatment Assessment (scores range from 1 to 7, with higher scores indicating better quality of life)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">837</enrollment>
  <condition>Stress Disorders, Post-Traumatic</condition>
  <arm_group>
    <arm_group_label>Telephone Monitoring</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Biweekly monitoring and support by telephone (up to 6 calls over 3 months) as augmentation to mental health care as usual.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment-As-Usual</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Mental health Treatment As Usual, potentially including case management, pharmacotherapy, and individual and/or group psychotherapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Telephone monitoring</intervention_name>
    <description>Three months of biweekly telephone monitoring and support</description>
    <arm_group_label>Telephone Monitoring</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Treatment-As-Usual</intervention_name>
    <description>Outpatient mental health Treatment As Usual (psychotherapy and/or medications)</description>
    <arm_group_label>Telephone Monitoring</arm_group_label>
    <arm_group_label>Treatment-As-Usual</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a PTSD diagnosis entering PTSD residential treatment with an intended
             length of stay of 15 days or longer (patients in brief evaluation or acute
             stabilization tracks will not be included, as their discharge plan may include
             readmission to residential treatment within a few months).

        Exclusion Criteria:

          1. Patients discharging from residential treatment within four days of
             admission(insufficient time to consent and assess them);

          2. Active Duty military personnel;

          3. Patients transferred from residential care to an inpatient medical unit due to
             emergent medical problems;

          4. Patients with traumatic brain injury or other organic impairment that compromises
             capacity to consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Craig S. Rosen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Palo Alto Health Care System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR</name>
      <address>
        <city>No. Little Rock</city>
        <state>Arkansas</state>
        <zip>72114-1706</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Battle Creek</name>
      <address>
        <city>Battle Creek</city>
        <state>Michigan</state>
        <zip>49015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Western New York Healthcare System, Buffalo, NY</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Coatesville</name>
      <address>
        <city>Coatesville</city>
        <state>Pennsylvania</state>
        <zip>19320</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Puget Sound Health Care System, Tacoma</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98493</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Rosen CS, Tiet QQ, Harris AH, Julian TF, McKay JR, Moore WM, Owen RR, Rogers S, Rosito O, Smith DE, Smith MW, Schnurr PP. Telephone monitoring and support after discharge from residential PTSD treatment: a randomized controlled trial. Psychiatr Serv. 2013 Jan;64(1):13-20.</citation>
    <PMID>23117443</PMID>
  </results_reference>
  <results_reference>
    <citation>Belsher BE, Tiet QQ, Garvert DW, Rosen CS. Compensation and treatment: disability benefits and outcomes of U.S. veterans receiving residential PTSD treatment. J Trauma Stress. 2012 Oct;25(5):494-502. doi: 10.1002/jts.21747. Epub 2012 Oct 9.</citation>
    <PMID>23047625</PMID>
  </results_reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 6, 2006</study_first_submitted>
  <study_first_submitted_qc>February 7, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2006</study_first_posted>
  <results_first_submitted>October 3, 2014</results_first_submitted>
  <results_first_submitted_qc>March 22, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 25, 2016</results_first_posted>
  <last_update_submitted>March 22, 2016</last_update_submitted>
  <last_update_submitted_qc>March 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>telemedicine</keyword>
  <keyword>treatment compliance</keyword>
  <keyword>mental health</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Veterans entering treatment in five 30-to-90 day residential treatment programs for posttraumatic stress disorder</recruitment_details>
      <pre_assignment_details>926 patients were initially consented into the study. 6 withdrew prior to randomization, and 83 met exclusion criteria after being consent (usually because they were discharged to another inpatient program, not to outpatient care). This left 837 subjects to be randomized.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Telephone Monitoring</title>
          <description>Telephone monitoring as augmentation to treatment as usual
Telephone case monitoring: Three months of biweekly telephone monitoring and support in addition to usual outpatient mental health care (psychotherapy and/or medications)</description>
        </group>
        <group group_id="P2">
          <title>Treatment-As-Usual</title>
          <description>Treatment as usual
Treatment as Usual Control: Usual outpatient mental health care (psychotherapy and/or medications)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="412"/>
                <participants group_id="P2" count="425"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Completed Intake Survey</title>
              <participants_list>
                <participants group_id="P1" count="408"/>
                <participants group_id="P2" count="417"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Completed 4 Month fu Survey</title>
              <participants_list>
                <participants group_id="P1" count="275"/>
                <participants group_id="P2" count="299"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Completed 12 Month fu Survey</title>
              <participants_list>
                <participants group_id="P1" count="257"/>
                <participants group_id="P2" count="281"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="310">310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.</participants>
                <participants group_id="P2" count="328">328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="102"/>
                <participants group_id="P2" count="97"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Did not complete intake</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="74"/>
                <participants group_id="P2" count="71"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Veterans entering residential treatment for posttraumatic stress disorder.</population>
      <group_list>
        <group group_id="B1">
          <title>Telephone Monitoring</title>
          <description>Telephone monitoring as augmentation to treatment as usual
Telephone case monitoring: Three months of biweekly telephone monitoring and support in addition to usual outpatient mental health care (psychotherapy and/or medications)</description>
        </group>
        <group group_id="B2">
          <title>Treatment-As-Usual</title>
          <description>Treatment as usual
Treatment as Usual Control: Usual outpatient mental health care (psychotherapy and/or medications)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="412"/>
            <count group_id="B2" value="425"/>
            <count group_id="B3" value="837"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50.2" spread="0.62"/>
                    <measurement group_id="B2" value="49.9" spread="0.86"/>
                    <measurement group_id="B3" value="50.0" spread="0.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                    <measurement group_id="B2" value="57"/>
                    <measurement group_id="B3" value="112"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="357"/>
                    <measurement group_id="B2" value="368"/>
                    <measurement group_id="B3" value="725"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="263"/>
                    <measurement group_id="B2" value="256"/>
                    <measurement group_id="B3" value="519"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="87"/>
                    <measurement group_id="B2" value="93"/>
                    <measurement group_id="B3" value="180"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Race/ethnicity missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Iraq or Afghanistan veteran</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Iraq/Afghanistan veteran</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="114"/>
                    <measurement group_id="B2" value="114"/>
                    <measurement group_id="B3" value="228"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Served prior to current Iraq/Afghanistan conflicts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="298"/>
                    <measurement group_id="B2" value="311"/>
                    <measurement group_id="B3" value="609"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Aggressive Behavior; Alcohol Misuse; Drug Misuse; PTSD Symptoms</title>
        <description>Higher scores are worse outcomes on all four measures:
Aggressive behavior (scale from 0-6 types of violent behavior than past four months) - adapted from conflict tactics scale Alcohol problems: Addiction Severity Index Alcohol composite (ranges from 0 to 1) Drug problems: Addiction Severity Index Drug composite (ranges from 0 to 1) PTSD symptoms: DSM IV PTSD Checklist (ranges from 17 to 85)</description>
        <time_frame>12 months post-discharge (8 months post intervention)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Telephone Monitoring</title>
            <description>Telephone monitoring as augmentation to treatment as usual
Telephone case monitoring: Three months of biweekly telephone monitoring and support in addition to usual outpatient mental health care (psychotherapy and/or medications)</description>
          </group>
          <group group_id="O2">
            <title>Treatment as Usual</title>
            <description>Treatment as usual
Treatment as Usual Control: Usual outpatient mental health care (psychotherapy and/or medications)</description>
          </group>
        </group_list>
        <measure>
          <title>Aggressive Behavior; Alcohol Misuse; Drug Misuse; PTSD Symptoms</title>
          <description>Higher scores are worse outcomes on all four measures:
Aggressive behavior (scale from 0-6 types of violent behavior than past four months) - adapted from conflict tactics scale Alcohol problems: Addiction Severity Index Alcohol composite (ranges from 0 to 1) Drug problems: Addiction Severity Index Drug composite (ranges from 0 to 1) PTSD symptoms: DSM IV PTSD Checklist (ranges from 17 to 85)</description>
          <units>Scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="412"/>
                <count group_id="O2" value="425"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PTSD Symptoms (PTSD Checklist)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.9" spread="13.0"/>
                    <measurement group_id="O2" value="63.4" spread="12.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aggressive Behavior</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" spread="2.2"/>
                    <measurement group_id="O2" value="3.1" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Alcohol Problems (ASI)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.15" spread="0.19"/>
                    <measurement group_id="O2" value="0.17" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Drug Problems (ASI)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.09"/>
                    <measurement group_id="O2" value="0.05" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Depressive Symptoms, Subjective Quality of Life</title>
        <description>Depression: Center for Epidemiological Studies Scale (ranges from 0 to 60, with higher scores indicating worse depression) Quality of Life: Scale from the Veterans Affairs Military Stress Treatment Assessment (scores range from 1 to 7, with higher scores indicating better quality of life)</description>
        <time_frame>12 months post-discharge (8 months post intervention)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Telephone Monitoring</title>
            <description>Telephone monitoring as augmentation to treatment as usual
Telephone case monitoring: Three months of biweekly telephone monitoring and support in addition to usual outpatient mental health care (psychotherapy and/or medications)</description>
          </group>
          <group group_id="O2">
            <title>Treatment-As-Usual</title>
            <description>Treatment as usual
Treatment as Usual Control: Usual outpatient mental health care (psychotherapy and/or medications)</description>
          </group>
        </group_list>
        <measure>
          <title>Depressive Symptoms, Subjective Quality of Life</title>
          <description>Depression: Center for Epidemiological Studies Scale (ranges from 0 to 60, with higher scores indicating worse depression) Quality of Life: Scale from the Veterans Affairs Military Stress Treatment Assessment (scores range from 1 to 7, with higher scores indicating better quality of life)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="408"/>
                <count group_id="O2" value="417"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Depression (CES-D)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.0" spread="10.1"/>
                    <measurement group_id="O2" value="38.4" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Quality of Life</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="1.1"/>
                    <measurement group_id="O2" value="3.3" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Rehospitalization</title>
        <description>Number of patients with psychiatric hospitalization within 12 months of discharge from PTSD program</description>
        <time_frame>12 months post discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Telephone Monitoring</title>
            <description>Biweekly monitoring and support by telephone (up to 6 calls over 3 months) as augmentation to mental health care as usual.
Telephone monitoring: Three months of biweekly telephone monitoring and support
TAU: Outpatient mental health Treatment As Usual (psychotherapy and/or medications)</description>
          </group>
          <group group_id="O2">
            <title>Treatment-As-Usual</title>
            <description>Mental health Treatment As Usual, potentially including case management, pharmacotherapy, and individual and/or group psychotherapy.
TAU: Outpatient mental health Treatment As Usual (psychotherapy and/or medications)</description>
          </group>
        </group_list>
        <measure>
          <title>Rehospitalization</title>
          <description>Number of patients with psychiatric hospitalization within 12 months of discharge from PTSD program</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="412"/>
                <count group_id="O2" value="425"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                    <measurement group_id="O2" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12 months</time_frame>
      <desc>Serious adverse events (primarily death and hospitalizations) were tracked for both arms of the study.</desc>
      <group_list>
        <group group_id="E1">
          <title>Telephone Monitoring</title>
          <description>Telephone monitoring as augmentation to treatment as usual
Telephone case monitoring: Three months of biweekly telephone monitoring and support in addition to usual outpatient mental health care (psychotherapy and/or medications)</description>
        </group>
        <group group_id="E2">
          <title>Treatment-As-Usual</title>
          <description>Treatment as usual
Treatment as Usual Control: Usual outpatient mental health care (psychotherapy and/or medications)</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="412"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="425"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization for cardiology or chest pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="412"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="425"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="412"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="425"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Hospitalization for overdose</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="412"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="425"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Scheduled laminotomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="412"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="425"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Psychiatric Hospitalization</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="412"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="425"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>kidney failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="412"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="425"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>hospitalized for cellulitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="412"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="425"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Death doe to causes not known</sub_title>
                <description>Cause of death not specified</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="412"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="425"/>
              </event>
              <event>
                <sub_title>Arrest or incarceration</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="412"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="425"/>
              </event>
              <event>
                <sub_title>Admitted to nursing home - reason not known</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="412"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="425"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="412"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Phone telephone care management upsetting</sub_title>
                <description>Telephone Monitoring arm: Participant was sufficiently upset by telephone calls to ask to discontinue intervention. Treatment as Usual arm: Not applicable (0 subjects at risk) because did not receive this intervention</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="412"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Craig S. Rosen</name_or_title>
      <organization>Nationa Center for PTSD Dissemination &amp; Training Division</organization>
      <phone>650-493-5000 ext 22812</phone>
      <email>craig.rosen@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

